Alphavirus Packaging Cell Lines Productivity and Safety
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Recombinant alphavirus particles production is limited by low particle yield and the risk of generating replication competent viral particles, which can occur during large-scale production, posing challenges in protein production and therapeutic applications.
Innovation Solution
The use of double subgenomic promoter expression cassettes and capsid autoproteolytic mutants to increase replicase complex availability and reduce the generation of replication competent viral particles, enhancing productivity and safety in alphavirus packaging cell lines.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If alphavirus packaging cell lines are used to generate large numbers of recombinant alphavirus particles, then productivity is improved, but the risk of generating replication competent viral particles increases
Solution Approach 1:
The alphavirus genome is divided into two separate defective helper cassettes: one containing structural protein genes (capsid and glycoprotein) and another containing nonstructural protein genes (nsP1-4). This segmentation ensures that each cassette is defective and cannot produce replication-competent virus alone, while together they can produce recombinant particles. The segmentation principle directly resolves the contradiction by enabling high productivity through scaled production while maintaining safety through genetic division.
Solution Approach 2:
A replicon RNA acts as an intermediary that provides the missing replication functions to the defective helper cassettes. The replicon contains the nsP1-4 genes and replication machinery that complement the structural protein-defective helper, enabling particle production without requiring the defective helpers to be complete. This intermediary approach allows scalable production while maintaining the safety of using defective components.
2Reliability
If defective helper cassettes are divided into two separate components, then the probability of recombination is reduced, but the complexity of the production system increases
Solution Approach 1:
The helper virus genome is segmented into two separate defective cassettes with distinct functional deficiencies. One cassette lacks structural proteins while the other lacks nonstructural proteins. This segmentation reduces recombination probability because multiple independent recombination events would be required to restore full virulence, while the modular design actually simplifies production by allowing independent optimization and validation of each component.
Solution Approach 2:
The system uses different promoters (subgenomic promoters) to control expression from each cassette, and employs specific RNA structures (3' UTR elements) to regulate replication. These parameter changes in gene expression control allow the complex segmented system to be managed efficiently, reducing the practical complexity despite the divided genome structure.
3Productivity
If capsid autoproteolytic activity is enhanced, then particle assembly is improved, but the risk of generating replication competent virus increases
Solution Approach 1:
The capsid autoproteolytic function is extracted and separated from the replication function. The capsid protein is engineered to retain its ability to assemble into particles and perform limited proteolytic processing, but the full autoproteolytic activity that could generate replication-competent virus is removed or inhibited. This extraction allows particle production while eliminating the harmful effect.
Solution Approach 2:
The capsid's natural autoproteolytic activity, which could potentially generate replication-competent virus by processing polyproteins, is converted into a benefit by controlling it to only perform necessary processing for particle assembly. The controlled autoproteolysis enables proper capsid maturation and particle formation while the defective nature of the cassettes prevents full viral replication, thus converting a potential harm into a useful function.
Data Source
AI summary
Strategies for increasing the productivity of alphavirus packaging cell lines and of reducing the possibility that replication competent virus may be generated during large scale production of recombinant alphavirus particles.